Processa Pharmaceuticals, Inc. Form D Notices of Exempt Offering of Securities
Notices filed with the SEC for securities sold without registration under Regulation D or Section 4(a)(5), newest first. Values are as filed.
- 2015-02-20: Federal exemption Rule 506(b); Securities Act Section 4(a)(5); Types of securities offered Debt; Date of first sale 2015-02-05; Total offering amount $2,000,000.
- 2013-05-28: Federal exemption Rule 506; 46; Types of securities offered Debt; Date of first sale 2013-05-22; Total offering amount $1,000,000.
| Filed | Federal exemption | Types of securities offered | Date of first sale | Total offering amount | Total amount sold | Total remaining to be sold | Investors who have already invested |
|---|
| 2015-02-20 | Rule 506(b); Securities Act Section 4(a)(5) | Debt | 2015-02-05 | $2,000,000 | $90,000 | $1,910,000 | 3 |
|---|
| 2013-05-28 | Rule 506; 46 | Debt | 2013-05-22 | $1,000,000 | $1,000,000 | $0 | 7 |
|---|